Valeant Offers to Buy Botox Maker Allergan

April 22 (Bloomberg) -- Valeant Pharmaceuticals International offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Scarlet Fu reports on Bloomberg Television’s “Bloomberg Surveillance.” (Source: Bloomberg)
Twitter's CEO Search: Who Are the Leading Candidates?
45:58 - Spark Capital's Nabeel Hyatt, IDC's Crawford Del Prete and Bloomberg's Sarah Frier discuss Twitter's CEO search with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Will FED "Jell" on September Liftoff?
  • Stocks Rebound: What to Expect for the Rest of the Year
  • Investor Sees 'Smile' for Economy in Dental Visits